Home Newsletters Pulmonary Cell News Cancer Stem-Like Cells Evade CD8+CD103+ Tumor-Resident Memory T (TRM) Lymphocytes by Initiating...

Cancer Stem-Like Cells Evade CD8+CD103+ Tumor-Resident Memory T (TRM) Lymphocytes by Initiating an Epithelial-to-Mesenchymal Transition Program in a Human Lung Tumor Mode

By
Justin.choi
-
0
Researchers supported the rational design of immunotherapeutic strategies targeting cancer stem cells to optimize their responsiveness to local CD8+CD103+ TRM cells for more efficient anticancer treatments.
[Journal For Immunotherapy of Cancer]
6445212 BBBBBBBB items 1 apa 0 default asc 1 174087 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article

RELATED ARTICLES

Exit mobile version